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Abstract: Pharmaceutical drug promotion practices are found to have potentially controversial ethical standards and may 
compromise on patient’s wellbeing especially when it inordinately affects the clinical care and patient’s interests by 
influencing the prescribing behavior of physicians. There is no proper system to keep a watch on the drug marketing and 
promotion strategies by the pharmaceuticals in Pakistan. A cross sectional study using a specially designed questionnaire 
and convenience sampling was conducted in Karachi for 6 months targeting prescribers and medical sales representative 
(MSRs). A total of 600 MSRs and prescribers consented to participate. 66% of MSRs highlighted that prescribers follow 
ethical prescribing but only (58%) seek evidence base behind promoted drug. This was contradictory to prescribers’ 
response to same, which was 87%. Only (10%) of prescribers acknowledged demanding expensive gifts such as laptops, 
ACs, furniture and renovation of the clinic from MSRs the fig. for which according to MSRs was about 40%. This study 
offered intricate insights into the MSR and physicians interactions. It highlighted various aspects of these relationships 
from both MSRs’ and prescribers’ point of view. Although majority of the physicians negated the notion of expecting 
expensive favors from the sales representatives, responses by the MSRs suggest that anticipation of gifts and incentives 
exists on part of the physicians which have the potential to indulge in unethical promotion and irrational prescribing on 
part of MSRs and prescribers respectively that can further contribute to untoward patient outcomes such as increased 
treatment costs and adverse drug reactions. 
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INTRODUCTION 
 
Pharmaceutical industry like other profit oriented 
industries has begun to narrowly focus on an overarching 
aim of maximizing profits. This profit driven approach is 
unfortunately intensifying the aggressive drug marketing 
and promotional practices in numerous ways. This can be 
judged from the fact that out of ten large pharmaceutical 
companies, nine were found to be spending far more on 
marketing budgets rather than investments in the research 
and development. (Anderson R, 2014) These drug 
promotional strategies have evolved over years.  From 
doling out freebies such as calendars and pens to more 
expensive gifts like cars and air conditioners, funding of 
medical activities such as grants for research projects, 
continuing medical education and payment for 
participation in international conferences and seminars, 
drug makers are known for incentivizing doctors to 
promote their products. (Schramm J et al, 2007) 
 
This is a matter of grave concern globally as many 
marketing practices are found to have potentially 
controversial ethical standards and may compromise on 
patient’s wellbeing especially when it inordinately affects 
the clinical care and patient’s interests by influencing the 
prescribing behavior of physicians. This leads to irrational 
prescribing and subsequently adverse drug reactions 
(ADRs). (Wazana A, 2000) This may take the form of 
over prescription, or doctors prescribing new or more 
expensive branded drugs despite the availability of 
inexpensive generics. (WHO, 1999) However this issue is 
of importance to developing countries where there are *Corresponding author: e-mail: naqviattaabbas@gmail.com 
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already existing issues such as those of counterfeit 
medicines and weak drug regulation mechanisms. (Ofori-
Asenso R et al, 2016) In this, irrational prescription of 
drugs because of unethical promotional practices adds to 
the misery of the economically impoverished society.  
 
In context of Pakistan, it is alarming that there is no 
proper system to keep a watch on the drug marketing and 
promotion strategies by the pharmaceutical firms which 
increases the likelihood of adverse drug reactions 
(ADRs). The role of pharmaceutical drug distributors and 
stockiest does not help the cause either. There have been a 
number of cases reported in the national media where 
they have ceased supplies of essential medicines and 
drugs to create an artificial drug shortage. This scenario 
results in more demand creation and reduced supply 
rendering medicines to be sold at exorbitant prices that 
further add to  untoward  patient  outcomes.  (Mansoor  H, 
2016) Since most of patients in Pakistan have to bear the 
burden of out of pocket spending on prescription of drugs, 
irrational pharmacotherapy further contributes to their 
burden significantly. (Zaidi S et al, 2011) 
 
METHODS 
 
A cross sectional survey using a specially designed 
questionnaire was conducted in the city of Karachi for the 
period of 6 months targeting prescribers and medical sales 
representative (MSRs). The study methodology adhered 
to STROBE guidelines. 
 
Target population and exclusion criteria 
The target population of the study included prescribers 
and medical sales representatives (MSRs). All inactive 
medical sales representatives and those working in non-
pharmaceuticals firms were excluded. Non-registered and 
non-practicing prescribers were also not included in the 
study.  
 
Sampling procedure and size 
The study employed convenient sampling to gather as 
many responses as possible. The respondents were 
approached in their free (off peak) time in out-patient 
clinics (OPD) of tertiary care hospitals in Karachi.  The 
sample size of the respondents was calculated using 
Raosoft ® (Raosoft, Inc. 6645 NE Windermere 
Road Seattle, WA 98115 USA) sample size calculator. 
(Raosoft Inc., 2017) According to Pakistan Medical and 
Dental Council (PM&DC), there are 47,947 registered 
practitioners practicing in the city of Karachi. (PM&DC, 
2017) This value was assumed as the total population size 
taking 95% confidence level and 5% alpha error. The 
sample size for prescribers was found to be 382. The 
number of medical sales representatives (MSRs) 
associated with pharmaceuticals in the city of Karachi is 
not known. Therefore, we assumed a fig. of 100,000 as 
our population for medical sales representatives’ sample 
size calculation and using the same confidence level and 
alpha margin of error, the sample size for MSRs obtained 
was 383. 
 
Study instrument 
A questionnaire was specially designed for the purpose of 
documenting the responses of prescribers and medical 
sales representatives (MSRs) the questionnaire had two 
(2) separate versions for both respondents. The 
questionnaire included questions related to the 
demographics and interaction between prescribers and 
MSRs occurring during drug promotion and prescribing. 
 
Piloting and validation procedure 
The questionnaire was formulated by a team of experts 
including academic professors, health care professionals 
including practicing pharmacists and physicians as well as 
social scientist. The research instrument was subjected to 
physical and statistical validation. It was piloted in 16 
MSRs and 19 prescribers. The average time to complete 
both versions questionnaire was 2-2.5 minutes. The 
research instrument was subjected to reliability analysis 
and value of Cronbach alpha (α) obtained was 0.743 for 
19 items which was considered satisfactory. The 
questionnaire was also subjected to Kaiser Mayer Olkin 
(KMO) measure of sampling adequacy that reported a 
value of 0.479 and Bartlett’s test for sphericity reporting 
significant p value of 0.0001. Furthermore, the research 
instrument underwent Exploratory Factor Analysis (EFA) 
using Principle component axis extraction and Promax 
rotation method with Kaiser Normalization that extracted 
4 components. Using the above-mentioned observations, 
the questionnaire was divided into versions A and B for 
prescribers and medical sales representatives (MSRs) and 
each version was divided into 2 sections i.e. demographic 
information and interactions. 
 
Data coding and analysis 
The data obtained from the respondents was coded in to 
categorical variables. The variables identified were work 
experience, work place and clinical affiliation of 
prescribers that was categorized as demographic 
information of prescribers. The variables of work 
experience, type of pharmaceutical firm and product 
group affiliation were categorized as demographic 
variables for medical sales representatives (MSRs). The 
interactions of prescribers with MSRs and vice versa were 
also categorized as a separate entity. The data was 
analyzed using Statistical Package for Social Sciences 
(SPSS Inc., IBM Corporation, New York, USA) version 
20. The demographic variables were expressed in 
frequency counts (N) and percentages (%). The study also 
employed chi–square X2 test for association and cross 
tabulation to check for association between the 
demographics and interactions. Level of significance (α) 
was determined at 0.05. 
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Informed consent and ethical approval 
Prior to the initiation of the study, the participants were 
briefed about the study and its objectives. A verbal 
consent was sought before handing the questionnaire. The 
study was subjected to, and was granted ethical approval 
by the Institutional Review Board of Clifton Hospital, 
Karachi 75600, Pakistan. (Ref # 234-1-15) 
RESULTS 
 
A total of 600 medical sales representatives and 
prescribers participated in our study. The demographic 
information of medical sales representatives revealed that 
most of them had a work experience of between 5-10 
years (N=276, 46%). Regarding the management team of 
Table 1: Demographic information for MSRs and Prescribers 
 
Demographics Sample (N) Percentage(%) P value Demographics Sample (N) Percentage (%) P value 
Work experience 0.0001 Work experience 0.0001 
> 5 years 264 44  > 5 years 121 20.2  
5 – 10 years 276 46  5 – 10 years 278 46.3  
>10 years 60 10  >10 years 201 33.5  
Total 600 100  Total 600 100  
Medicines group 0.624 Affiliated Clinical domain 0.011 
General 306 51  General 331 55.2  
Specialty 294 49  Consultant 269 44.8  
Total 600 100  Total 600 100  
Pharmaceutical Manufacturer 0.0001 Hospital 0.0001 
Local/National 408 68  Private Sector 418 69.7  
Multinational 192 32  Public Sector 182 30.3  
Total 600 100  Total 600 100  
 
Table 2: Interactions between MSRs and prescribers 
 
Interactions Sample (N) Percentage (%) P value Interactions Sample(N) Percentage (%) P value 
MSRs expectation from prescribers  Prescribers’ expectations from MSRs  
Prescribers follow ethical practice 0.0001 Good communications and drug detailing skills 0.0001 
Yes 401 66.8  Yes 486 81  
No 199 33.2  No 114 19  
Total 600 100  Total 600 100  
Knowledge and evidence base sought by prescribers 
behind promoted/ drug 
0.0001 
Knowledge and evidence base expected from MSRs 
regarding promoted/ detailed drug 
0.0001 
Yes 348 58  Yes 522 87  
No 252 42  No 78 13  
Total 600 100  Total 600 100  
Prospects of inducements i.e. gifts, samples and 
luxury expected by prescribers 
0.0001 
Prospects of inducements i.e. gifts, samples and luxury 
asked from MSRs 
0.624 
Yes 378 63  Yes 240 40  
No 222 37  No 360 60  
Total 600 100  Total 600 100  
Continuous Medical Education CME opportunities 
expected by prescribers 
0.0001 
Continuous Medical Education CME opportunities 
expected from MSRs 
0.0001 
Yes 192 32  Yes 486 81  
No 408 68  No 114 19  
Total 600 100  Total 600 100  
Expensive gifts such as laptops, air conditioners and 
furniture expected by prescribers 
0.0001 
Expensive gifts such as laptops, air conditioners and 
furniture expected from MSRs 
0.0001 
Yes 228 38  Yes 66 11  
No 372 62  No 534 89  
Total 600 100  Total 600 100  
Lunch, paid holiday trips to be offered from MSRs 
expected by prescribers 
0.0001 Lunch, paid holiday trips asked by prescribers 0.0001 
Yes 234 39  Yes 216 36  
No 366 61  No 384 64  
Total 600 100  Total 600 100  
Prescribers indulge in irrational prescribing to avail 
inducement 
0.0001 MSRs ignore patient health for sake of increasing sales 0.0001 
Yes 99 16.5  Yes 421 70.2  
No 501 83.5  No 179 29.8  
Total 600 100  Total 600 100  
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MSRs, the survey incorporated almost equal number of 
MSRs from general medicines (N=306, 51%) and 
specialty medicines group (N=294, 49%). More than half 
of MSRs (N=408, 68%) were associated with 
local/national pharmaceutical manufacturers. All the 
findings except medicines group of MSRs were 
statistically significant i.e. p value less than 0.05. The 
demographic information is presented in table 1. 
 
Furthermore, the data of the interactions between MSRs 
and prescribers revealed significant findings. From the 
perspective of MSRs, more than half of the MSRs (N= 
401, 66.8%) mentioned that the prescribers whom they 
interacted with, followed ethical prescribing practice. 
Additionally, they also revealed that slightly more than 
half of the prescribers (N=348, 58%) sought evidence 
base regarding the promoted drug. Regarding the 
prospects of inducements and luxury more than half of the 
MSRs (N=378, 63%) revealed that prescribers expected 
them to offer such provisions and a third (N=228, 38%) 
and (N=234, 39%) further mentioned that prescribers 
demanded for expensive gift items such as overseas 
holidays, air tickets, laptops, air conditioners (AC), 
furniture and renovation of the clinic respectively. Only a 
third proportion of the MSRs (N=192, 32%) mentioned 
that prescribers asked for continuous medical education 
(CME).  
 
A very small segment of MSRs (N=99, 16.5%) 
highlighted that prescribers often indulged in irrational 
prescribing to avail the inducements. All the findings 
obtained were statistically significant i.e. p value less than 
0.05. 
 
From the perspective of prescribers, an overwhelming 
majority of prescribers (N=486, 81%) mentioned that they 
only expected effective communication and drug detailing 
skills from MSRs in order to be convinced for prescribing 
a promoted drug. Furthermore, similarly majority (N= 
522, 87%) highlighted that they sought evidence base 
from MSRs regarding detailed product. Regarding 
prospects of inducements i.e. gifts and samples of drugs 
expected from MSRs, more than half of the prescribers (N 
=240, 40%) responded negatively with almost 90% of 
them (N=534, 89%) negating the notion of demanding 
above mentioned expensive gifts from MSRs. However, a 
third of prescribers (N=216, 36%) acknowledged that they 
expected free lunch, paid overseas holidays from MSRs. 
Regarding CME, majority of the prescribers (N=486, 
81%) mentioned that they always try to inquire about 
such opportunities from MSRs. Lastly, the prescribers 
were asked if MSRs ignore patient health for the sake of 
increasing their sales to which majority of the prescribers 
(N=421, 70.2%) were in agreement. All the findings 
except for the question of inducement prospects are 
statistically significant i.e. p value <0.05. The summary 
of the interactions between MSRs and prescribers is 
presented in table 2. 
The demographic variables of medical sales 
representatives (MSRs) and interactions with prescribers 
were cross tabulated to check for associations using chi 
square X
2
 test for association. There was no statistical 
significance between work experience of MSRs and 
prescribers following ethical practice (p value>0.05). The 
variable of work experience of MSRs was statistically 
significant with prescriber’s quest for evidence base 
behind promoted drug with p value less than 0.05 and 
weak to moderate effect size i.e. phi value reported at 
0.143. It was also statistically associated with prescribers’ 
demand for continuous medical education (CME) i.e. p 
value <0.05 and moderate effect size i.e. phi reported at 
0.240. Furthermore, the work experience of MSRs and 
prescribers’ demand for expensive gifts such as laptops, 
air conditioners (AC), furniture and renovation of the 
clinic, had significant association with p value less than 
0.05 and strong effect size i.e. phi reported at 0.420. 
Further to this, the variable of prescribers’ demand for 
free lunch, overseas holidays and air tickets was 
significantly associated with, the work experience of 
MSRs with p value reported 0.0001 i.e. less than 0.05 and 
strong effect size i.e. phi reported at 0.454. In addition, 
there was statistically significant association between 
work experience, and prescribers indulging in irrational 
prescribing to avail inducements. (P value<0.05 and phi 
value reported at 0.105). 
 
The demographic variable of medicines group of MSRs 
was also tested for association with the variable of 
prescribers’ quest for evidence base behind promoted 
drug. It was statistically significant with p value less than 
0.05 but weak effect size i.e. phi reported at 0.017. 
Similarly, medicines group was statistically associated 
with prescribers’ demand of expensive gifts, p value 
reported at 0.0001 i.e. less than 0.05 with moderate to 
strong effect size i.e. phi value = 0.304. Furthermore, the 
association of same demographic variable was also 
significant (p value<0.05, phi value at 0.201) with 
prescribers’ expectation of free lunches, overseas holiday 
trips and air tickets from MSRs.  
 
Finally, the demographic variable of workplace of MSRs 
was also tested for association with the above-mentioned 
variables of interactions. The organization of MSRs was 
statistically associated (p value<0.05) with prescribers 
demand for evidence base regarding promoted drug 
having a weak to moderate effect (phi value at 0.198); 
prospects of inducements such as gifts and samples of 
drugs (p value<0.05, phi value at 0.126); expensive gifts 
(p value<0.05, phi value at 0.17); free lunches, overseas 
holiday trips (p value<0.05, phi value 0.505) and CME (p 
value<0.05, phi value 0.173). The summary of 
association of MSRs’ demographic variables and their 
interactions with prescribers is tabulated in table 3. 
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Table 3: Association of demographic variables of medical sales representatives with their personal experience 
 
Demographic variable 
Perceptions of MSRs regarding prescribers P value Phi 
Observed N (Expected N)   
Work Experience Prescribers follow ethical practice 0.904 0.018 
 Yes No   
<5 years 178 (176.4) 86 (87.6)   
5 – 10 years 182 (184.5) 94 (91.5)   
>10 years 41 (40.1) 19 (19.9)   
Work Experience Knowledge and evidence base sought by prescribers behind promoted/ drug 0.002 0.143 
<5 years 174 (153.1) 90 (110.9)   
5 – 10 years 144 (160.1) 132 (115.9)   
>10 years 30 (34.8) 30 (25.2)   
Work Experience Continuous Medical Education CME opportunities expected by prescribers 0.0001 0.240 
<5 years 84 (84.5) 180 (179.5)   
5 – 10 years 108 (88.3) 168 (187.7)   
>10 years 0 (19.2) 60 (40.8)   
Work Experience 
Expensive gifts such as laptops, air conditioners and furniture expected by 
prescribers 
0.0001 0.420 
<5 years 66 (100.3) 198 (163.7)   
5 – 10 years 162 (104.9) 114 (171.1)   
>10 years 0 (22.8) 60 (37.2)   
Work Experience Lunch, paid holiday trips to be offered from MSRs expected by prescribers 0.0001 0.454 
<5 years 60 (103) 204 (161)   
5 – 10 years 114 (107.6) 162 (168.4)   
>10 years 60 (23.4) 0 (36.6)   
Work Experience Prescribers indulge in irrational prescribing to avail  inducement 0.037 0.105 
<5 years 45 (43.6) 219 (220.4)   
5 – 10 years 51 (45.5) 225 (230.5)   
>10 years 3 (9.9) 57 (50.1)   
Medicine group Knowledge and evidence base sought by prescribers behind promoted/ drug 0.017 0.098 
General 192 (177.5) 114 (128.5)   
Specialty 156 (170.5) 138 (123.5)   
Medicines group 
Expensive gifts such as laptops, air conditioners and furniture expected by 
prescribers 
0.0001 0.304 
General 72 (116.3) 234 (189.7)   
Specialty 156 (111.7) 138 (182.3)   
Medicines group Continuous Medical Education CME opportunities expected by prescribers 0.0001 0.443 
General 36 (97.9) 270 (208.1)   
Specialty 156 (94.1) 138 (199.9)   
Medicines group Lunch, paid holiday trips to be offered from MSRs expected by prescribers 0.0001 0.201 
General 90 (119.3) 216 (186.7)   
Specialty 144 (114.7) 150 (179.3)   
Organization Knowledge and evidence base sought by prescribers behind promoted/ drug 0.0001 0.198 
Local/National 264 (236.6) 144 (171.4)   
Multinational 84 (111.4) 108 (80.6)   
Organization Prospects of inducements i.e. gifts, samples and luxury expected by prescribers 0.002 0.126 
Local/National 240 (257) 168 (151)   
Multinational 138 (121) 54 (71)   
Organization 
Expensive gifts such as laptops, air conditioners and furniture expected by 
prescribers 
0.0001 0.170 
Local/National 132 (155) 276 (253)   
Multinational 96 (73) 96 (119)   
Organization Continuous Medical Education CME opportunities expected by prescribers 0.0001 0.173 
Local/National 108 (130.6) 300 (277.4)   
Multinational 84 (61.4) 108 (130.6)   
Organization Lunch, paid holiday trips to be offered from MSRs expected by prescribers 0.0001 0.505 
Local/National 228 (159.1) 180 (248.9)   
Multinational 6 (74.9) 186 (117.1)   
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Similarly, the demographic variables of prescribers were 
also tested for statistically significant association with 
their interactions with MSRs. The results revealed that the 
work experience of prescribers was statistically associated 
(p value less than 0.05) with the variable of, MSRs 
ignoring patient health for the sake of increasing sales; 
having a strong effect (phi value 0.459). The demographic 
variable of affiliated clinical domain of prescriber was 
also significantly associated with the same with p value 
less than 0.05 and weak to moderate effect size i.e. phi 
value reported at 0.101. The summary of association of 
prescribers’ demographic variables and their interactions 
with MSRs is tabulated in table 4. 
 
The data obtained from medical sales representatives 
(MSRs) and prescribers revealed conflicting findings. 
According to the MSRs, slightly more than a half of the 
prescribers (N=348, 58%) sought evidence base behind 
promoted drug the fig. for which, according to 
prescribers, was more than 80% i.e. (N=522, 87%). 
Similarly regarding CME opportunities, the figs. were 
conflicting as MSRs reported only a third of prescribers 
(N=192, 32%) sought CME opportunities. However 
according to the prescribers 8/10 (N=486, 81%) 
prescribers sought such opportunities from MSRs. 
Furthermore, only a tenth proportion of prescribers 
acknowledged demanding expensive gifts such as laptops, 
ACs, furniture and renovation of the clinic from MSRs 
the fig. for which, according to MSRs, was about 40% i.e. 
(N=234, 39%). The summary of interaction conflicts is 
presented in fig. 1. 
 
DISCUSSION 
 
This study was conducted in the city of Karachi, Pakistan 
to document the drug promotion and prescribing practice 
prevailing in the health sector. For this purpose the 
medical sales representatives and prescribers were 
approached with a questionnaire. A total of 600 medical 
sales representative and prescribers participated in the 
study. Most of the MSRs had a work experience of 
between 5 to 10 years.  This was quite expected as MSRs 
after spending a considerable period of time in the field 
were promoted to higher managerial positions rendering 
them in offices rather than in the field. They mostly 
become part of the project management teams (PMT) 
supervising the sales force for a particular medicine 
group. (Khan N et al, 2016 )  
 
In supersession to this, the survey incorporated MSRs 
from general (51%) and specialty (49%) medicine groups 
as well as from local and multinational pharmaceutical 
firms. A general medicine group may contain any 
medicine for an ailment and/or any OTC product that may 
be prescribed by a general physician. For the specialty 
medicines, this category may include medicines mostly 
prescribed by consultants and/or patented products 
exclusively marketed by a pharmaceutical firm and/or 
specialized products such as biological, CNS stimulants, 
etc. (ACP, 2017). The profit margin is more in the latter 
group. (Anderson R, 2014) Furthermore, the MSRs were 
approached from both local and multinational 
pharmaceutical firms. According to the Pakistan 
Pharmaceutical Manufacturer’s Association (PPMA), the 
pharma sector of the country comprises of around 400 
pharmaceutical manufacturing facilities with 25 run by 
the multinationals groups and market share in terms of 
products is almost equally distributed between the two. 
(PPMA, 2016) Hence, it was essential to incorporate the 
views from MSRs belonging to both pharmaceutical 
manufacturers.  
 
With regards to the prescribers, most of them (46.3%) 
appeared to be in practice for around 5-10 years and a 
very small segment having work experience of more than 
10 years. The latter is a significant finding in the Pakistani 
context as the country has been subjected to the 
phenomenon of brain drain of skilled professionals 
including pharmacists and physicians. (Naqvi AA et al, 
2017) As a result, most of the health professionals who 
had stayed and practiced medicine for some time in 
Pakistani health care system moved and settled abroad. 
(Khan N, 2016) The survey incorporated both general 
practitioners (55.2%) and consultants (44.8%) and most 
of the prescribers (69.7%) were affiliated to private sector 
hospitals. Pakistan’s health care system is distributed in to 
public and privately owned health care institutions 
therefore, it was imparative to incorporate views of 
prescribers from both sectors. (Zaidi S et al, 2013), (Zehra 
F et al, 2017). 
Table 4: Association of demographic variables of prescribers with interactions 
 
Demographic variable 
Perceptions of MSRs regarding prescribers P value Phi 
Observed N (Expected N)   
MSRs ignore patient health for sake of increasing sales 0.0001 0.459 
Work Experience Yes No   
<5 years 37 (84.9) 84 (36.1)   
5 – 10 years 205 (195.1) 73 (82.9)   
>10 years 179 (141) 22 (60)   
Affiliated Clinical domain MSRs ignore patient health for sake of increasing sales 0.015 0.101 
General 246 (232.3) 85 (98.7)   
Consultant 175 (188.7) 94 (80.3)   
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Regarding the interactions between MSRs and prescribers 
from MSRs’ reflected experience; it was observed that 
majority (66.8%) of the MSRs experienced that 
prescribers followed ethical practice and slightly more 
than half (58%) reported knowledge and evidence base 
seeking attitude regarding promoted drug being exhibited 
by prescribers during drug detailing. The latter was also 
statistically associated with the work experience of the 
MSRs (p value <0.05). Knowledge and evidence base 
seeking attitude of the prescribers were reported more 
than expected count for by MSRs having a work 
experience of less than 5 years that drops to observed 
counts less than expected for increasing experience. This 
can related to the fact that prescribers are weary of sales 
representatives who are relatively new in their career. As 
they progress in their career, drug detailing meeting 
transcends knowledge and evidence base to banking upon 
mainly on communication skills and personal contacts. 
(Khan N et al, 2016)  
 
The demographic variable of MSRs’ organization was 
also statistically associated with the knowledge and 
evidence base seeking attitude of prescribers (p value 
<0.05). The observed count for MSRs belonging to 
local/national pharmaceutical firms was reported higher 
than expected which implies that prescribers seek 
knowledge and evidence base behind promoted drug more 
aggressively from MSRs working for local firms as 
compared to the multinationals.  One of the reasons 
supporting this concept is the fact that multinationals have 
more credibility and investment on quality of medications 
as compared to their national counterparts. Products from 
multinational pharmaceuticals are appropriately marketed 
to the prescribers as a result; they are ingrained with the 
thought of prescribing a brand over generic. Studies have 
reported the negative perceptions regarding generic 
prescribing among health professionals in Pakistan and 
have highlighted the thought of comprised quality 
associated with the generic medicines in the minds of 
prescribers. Thus, MSRs associated with a local 
pharmaceutical firm who detail about a generic drug often 
find themselves being inquired to a greater extent by the 
prescribers regarding the product as compared to those 
belonging to multinationals. (Zehra F et al, 2017), 
(Jamshed SQ et al, 2011)  
 
Furthermore, most of the sales representatives (63%) 
reported prescribers exploring the prospects of gifts and 
drugs samples as they reflected on to their experience 
with more than a third proportion (38%) mentioning the 
demands of expensive gifts such as laptops, ACs, 
furniture and renovation of the clinic. Moreover, a similar 
proportion of MSRs (39%) also shared their account of 
interaction with prescribers expecting free lunches, paid 
holidays trips, air tickets to be offered. The variables of 
gifts were statistically associated (p value <0.05) with the 
work experience, medicines group and organization of 
MSRs. The cross tabulated data revealed that the 
observed counts for MSRs with 5-10 years experience 
exceed the expected counts. This can be related with the 
previous association of experience with knowledge 
seeking. As the MSRs progress in their career, their 
 
 
Fig. 1: Self reported interaction conflicts between MSRs and Prescribers 
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relationship with prescribers develops on communication 
and mutual trusts that sometimes lead to both parties 
exploring grey areas for personal gains. Sale is a target 
oriented job, the sales representatives may request a 
prescriber to prescribe their brand to facilitate monthly 
sales target completion and in due course, may offer some 
inducement for doing so. At the same time the prescriber 
may demand the same in return for the favor. With 
regards to medicines group, observed counts exceeded 
expected counts for specialty group. It is evident that 
specialty group accounts for medicines having more 
margins of profits hence, this medicines group is prone to 
be exposed to inducements demand. The MSRs were 
further enquired regarding the opportunities for 
continuous medical education (CME) expected by 
prescribers to which only a third of MSRs (32%) 
mentioned prescribers seeking such prospects during their 
meetings. This was also significantly associated with 
experience (p value <0.05) and can be related in the same 
way as for prospects of inducements. The former was also 
associated with the medicines group and organization of 
MSRs (p value <0.05). It is quite common since the 
pharmaceuticals target consultants for most part to 
promote their specialty medicines and in that context, it is 
justified to offer CME opportunities to the prescribers to 
empower them in knowledge. However, an overwhelming 
majority (83.5%) negated the notion of prescribers 
indulging in irrational prescribing to avail inducements 
during their interactions. 
 
With regards to the prescribers, the work experience and 
their clinical domain was statistically associated (p value 
less than 0.05) with their reflection of MSRs ignoring 
patient health for sake of increasing the sales. It appeared 
that prescribers practicing between 5 to 10 years and 
those having an experience of more than 10 years were of 
the view that MSRs ignore patient health for sake of 
increasing the sales more than expected. Furthermore, 
general practitioners were observed to be more in count as 
compared to the expected who had the same view. 
 
One of the notable features of the study was the conflict 
of interests observed between the two respondent groups 
regarding drug detailing and prescribing practices. There 
were conflicting results obtained as only a half segment of 
MSRs (58%) highlighted knowledge and evidence base 
seeking attitude of prescribers during detailing which was 
contradictory to the response given by the prescribers. 
According to the prescribers, an overwhelming majority 
(81%) sought knowledge and evidence base behind 
promoted drug. Similar conflicts were observed in 
response of both groups to the notion of expensive gifts 
such as laptops, ACs, furniture and clinic renovation as an 
inducement for drug prescribing. According to the MSRs, 
more than a third proportion of prescribers expected 
MSRs to offer such inducements however, when response 
to the same was sought from prescribers, only a tenth 
proportion acknowledged expecting such inducements 
from MSRs. Moreover, the trend was the same for CME 
opportunities. According to MSRs, only a third of 
prescribers appeared interested in benefiting from CME 
opportunities offered by MSRs. Contrastingly, an 
overwhelming majority of prescribers highlighted their 
interest in benefiting from such opportunities offered by 
MSRs. 
 
CONCLUSION 
 
This study offered intricate insights into the MSR and 
physicians interactions. It highlighted various aspects of 
these relationships from both MSR and physician point of 
views. Although majority of the physicians negated the 
notion of expecting expensive favors from the sales 
representatives, responses by the MSRs suggest that 
anticipation of gifts and incentives exists on part of the 
physicians. This calls for establishment of ethical 
guidelines for drug promotion in the country. Institutional 
intervention is also required so that a proper mechanism is 
put in place to assess various promotional activities by the 
pharmaceutical companies. This has potential to curb 
unethical prescribing that may reduce the likelihood of 
patients suffering from adverse drug reactions (ADRs) 
and increasing direct health costs. 
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